CD133 expression in glioblastoma multiforme: A literature review

Authors

Syed Ijlal Ahmed, Aga Khan University
Gohar Javed, Aga Khan UniversityFollow
Altaf Ali Laghari, Aga Khan UniversityFollow
Syeda Beenish Bareeqa, Jinnah Medical and Dental College, Karachi, PAK.
Saba Farrukh, Liaquat National Hospital and Medical College, Karachi, PAK.
Shajeeah Zahid, Liaquat National Hospital and Medical College, Karachi, PAK.
Syeda Sana Samar, Jinnah Sindh Medical University, Karachi, PAK.
Kashif Aziz, Icahn School of Medicine at Mount Sinai/Queens Hospital Center, USA.

Document Type

Article

Department

Neurosurgery

Abstract

Glioblastoma, also known as glioblastoma multiforme (GBM), is the most common primary brain tumor. Extensive research has been carried out to discover the factors associated with the course and progression of GBM. CD133 is a glycoprotein antigen found in normal and malignant tissues. CD133 has been recognized as a marker for the growth of cancer cells. The association between this tissue marker and GBM is being investigated. The aim of this review was to evaluate the role of CD133 as a tumor marker for the prognosis of GBM.

Comments

Pagination are not provided by the author/publisher

Publication (Name of Journal)

Cureus

Recommended Citation

Ahmed, S., Javed, G., Laghari, A., Bareeqa, S., Farrukh, S., Zahid, S., Samar, S. S., Aziz, K. (2018). CD133 expression in glioblastoma multiforme: A literature review. Cureus, 10(10), e3439.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_surg_neurosurg/170

Creative Commons License

This work is licensed under a Creative Commons Attribution 3.0 License.